Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 21408 results
Advanced filters: Author: L J Fisher Clear advanced filters
  • Functional studies of O-GlcNAcylation have often focused on individual modifications. Now, a systems-level approach has identified simultaneous O-GlcNAcylation events that coordinate cellular activities and tissue-specific functions.

    • Matthew E. Griffin
    • John W. Thompson
    • Linda C. Hsieh-Wilson
    ResearchOpen Access
    Nature Chemical Biology
    P: 1-12
  • Native top-down proteomics reveals epidermal growth factor receptor–estrogen receptor-alpha (EGFR–ER) signaling crosstalk in breast cancer cells and dissociation of nuclear transport factor 2 (NUTF2) dimers to modulate ER signaling and cell growth.

    • Fabio P. Gomes
    • Kenneth R. Durbin
    • John R. Yates III
    Research
    Nature Chemical Biology
    Volume: 21, P: 1205-1213
  • Non-invasive strategies to detect and track activated myeloid cells will facilitate disease diagnosis and monitoring in patients affected by neuroinflammatory disorders. Here, the authors present 18F-FMD, a dendrimer-based PET tracer that detects and monitors activated myeloid cells at different stages (presymptomatic and symptomatic) of Experimental Autoimmune Encephalomyelitis (EAE) in mice and in response to disease-modifying therapies.

    • Renesmee C. Kuo
    • Mackenzie L. Carlson
    • Michelle L. James
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-14
  • Donahue et al. show that ageing is associated with changes in ER morphology. ER-phagy drives age-associated ER remodelling through tissue-specific factors.

    • Eric K. F. Donahue
    • Nathaniel L. Hepowit
    • Kristopher Burkewitz
    ResearchOpen Access
    Nature Cell Biology
    P: 1-16
  • WIN332 is an HIV-1 Env protein designed to elicit a new class of Asn332-glycan-independent antibodies (type II) to the V3-glycan site of Env. WIN332 immunization rapidly induces type-II V3-glycan antibodies with low inhibitory activity indicative of a neutralization activity in macaques.

    • Ignacio Relano-Rodriguez
    • Jianqiu Du
    • Amelia Escolano
    ResearchOpen Access
    Nature Immunology
    P: 1-14
  • The xylosyltransferase isoenzymes XT1 and XT2 catalyze the first glycosylation step in the biosynthesis of proteoglycans. Now, bump-and-hole engineering of XT1 and XT2 enables substrate profiling and modification of proteins as designer proteoglycans to modulate cellular behavior.

    • Zhen Li
    • Himanshi Chawla
    • Benjamin Schumann
    ResearchOpen Access
    Nature Chemical Biology
    P: 1-10
  • Systematic screening of transcription factors reveals conserved mechanisms governing cortical radial glia lineage progression across primates and provides a framework for functional dissection of gene regulatory networks in human cortical neurogenesis.

    • Jingwen W. Ding
    • Chang N. Kim
    • Alex A. Pollen
    ResearchOpen Access
    Nature
    P: 1-11
  • Scholl et al. show that PopZ forms filamentous condensates driven by its helical domain and inhibited by its disordered region. Phase-dependent conformations modulate client interactions and disruption of filamentation or condensation impairs cellular function and growth.

    • Daniel Scholl
    • Tumara Boyd
    • Keren Lasker
    ResearchOpen Access
    Nature Structural & Molecular Biology
    P: 1-13
  • Taveneau et al. leverage artificial-intelligence-driven protein design to create inhibitors that control RNA-targeting enzymes in cells, revealing a strategy to rapidly design off-switches for RNA-editing systems.

    • Cyntia Taveneau
    • Her Xiang Chai
    • Gavin J. Knott
    ResearchOpen Access
    Nature Chemical Biology
    P: 1-9
  • The distinct architecture of the Escherichia coli membrane transporter LetA mediates lipid trafficking across the bacterial envelope in partnership with the tunnel-like complex LetB.

    • Cristina C. Santarossa
    • Yupeng Li
    • Gira Bhabha
    ResearchOpen Access
    Nature
    P: 1-10
  • In a phase 2 trial evaluating healthy donor fecal microbial transplantation plus either anti-PD-1 in patients with non-small cell lung cancer or anti-PD-1 and anti-CTLA-4 in patients with melanoma, encouraging efficacy was seen in both cohorts, with responses linked to significantly greater loss of baseline bacterial species.

    • Sreya Duttagupta
    • Meriem Messaoudene
    • Arielle Elkrief
    ResearchOpen Access
    Nature Medicine
    P: 1-14
  • Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.

    • Renee R. Fedak
    • Rachel N. Ruggerie
    • Kelly Gwathmey
    ResearchOpen Access
    Nature Medicine
    P: 1-13
  • An in-depth analysis of tissue biopsies from patients with multiple myeloma and CAR T cell therapy-associated immune-related adverse events (CirAEs) after treatment with commercial BCMA-targeted CAR T cell therapy shows that CD4+ CAR T cells mediate off-tumor toxicities and that high CD4:CD8 ratio at apheresis, robust early CAR T cell expansion, ICANS and ciltacabtagene autoleuce treatment are independently associated with the development of CirAEs.

    • Matthew Ho
    • Luca Paruzzo
    • Joseph A. Fraietta
    Research
    Nature Medicine
    P: 1-15
  • Glucose deprivation triggers the secretion of the cytokine LIF, which promotes angiogenesis and immune suppression in lung cancer models.

    • Fedra Luciano-Mateo
    • Joaquim Moreno-Caceres
    • Cristina Muñoz-Pinedo
    Research
    Nature Metabolism
    P: 1-21
  • De novo and inherited dominant variants in genes encoding U4 and U6 small nuclear RNAs are identified in individuals with retinitis pigmentosa. The variants cluster at nucleotide positions distinct from those implicated in neurodevelopmental disorders.

    • Mathieu Quinodoz
    • Kim Rodenburg
    • Carlo Rivolta
    ResearchOpen Access
    Nature Genetics
    Volume: 58, P: 169-179
  • A technique called condense-seq has been developed to measure nucleosome condensability and used to show that mononucleosomes contain sufficient information to condense into large-scale compartments without requiring any external factors.

    • Sangwoo Park
    • Raquel Merino-Urteaga
    • Taekjip Ha
    ResearchOpen Access
    Nature
    Volume: 643, P: 572-581
  • The anterior cingulate cortex encodes affective pain behaviours modulated by opioids; targeting opioid-sensitive neurons through a new chemogenetic gene therapy replicates the analgesic effects of morphine, providing precise chronic pain relief without affecting sensory detection.

    • Corinna S. Oswell
    • Sophie A. Rogers
    • Gregory Corder
    ResearchOpen Access
    Nature
    Volume: 649, P: 938-947
  • A platform using matched patient-derived lung tumouroids and healthy lung organoids enables accurate examination of patient responses to CAR T therapy and offers a faithful framework for improved CAR T design.

    • Lukas Ehlen
    • Martí Farrera-Sal
    • Michael Schmueck-Henneresse
    ResearchOpen Access
    Nature Biomedical Engineering
    P: 1-17
  • This report describes a nanobody targeting glycine receptor mGlyR that inhibits its ability to regulate G protein signaling and produces anti-depressant effects in mice providing an immunotherapy approach to potentially treat depression.

    • Thibaut Laboute
    • Stefano Zucca
    • Kirill A. Martemyanov
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-15
  • The tolerogenic activity of type 1 conventional dendritic cells (cDC1s) is determined by EPOR, which is preferentially expressed in cDC1s and induces antigen-specific FOXP3-expressing regulatory T cells.

    • Xiangyue Zhang
    • Christopher S. McGinnis
    • Edgar G. Engleman
    Research
    Nature
    P: 1-11
  • Ramaglia and colleagues show that aberrant formation of B cell-rich lymphoid structures in the brain meninges is associated with high CXCL13:BAFF ratios. Inhibiting the kinase BTK reduces the lymphotoxin signaling needed to sustain such structures, lowers CXCL13:BAFF ratios and reduces cortical tissue injury.

    • Ikbel Naouar
    • Andrei Pangan
    • Valeria Ramaglia
    Research
    Nature Immunology
    Volume: 27, P: 48-60
  • Large-effect variants in autism remain elusive. Here, the authors use long-read sequencing to assemble phased genomes for 189 individuals, identifying pathogenic variants in TBL1XR1, MECP2, and SYNGAP1, plus nine candidate structural variants missed by short-read methods.

    • Yang Sui
    • Jiadong Lin
    • Evan E. Eichler
    ResearchOpen Access
    Nature Communications
    P: 1-16
  • In a randomized controlled trial that included 97 participants, 69% patients with Crohn’s disease (CD) allocated to a fasting-mimicking diet (FMD) achieved clinical response, and over 60% reached remission, outperforming the control group. The FMD also reduced markers of intestinal inflammation, suggesting this dietary intervention could serve as adjunctive treatment for CD.

    • C. Kulkarni
    • T. Fardeen
    • S. R. Sinha
    Research
    Nature Medicine
    P: 1-11
  • Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immune cell infiltration and reduce recurrence in aggressive TNBC models.

    • Diego A. Pedroza
    • Xueying Yuan
    • Jeffrey M. Rosen
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-20
  • Therapeutic gene editing in vivo is an ongoing challenge. Here, authors demonstrate Cas9 nickase guided DNA ligation as a nonviral method for installing permanent genomic corrections with favorable on target edit profiles in model animal cell types and adult mice.

    • Angela X. Nan
    • Michael Chickering
    • Jenny Xie
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-13
  • The famous nebula Barnard 68 has been used as a giant cosmic-ray detector: cosmic-ray-excited vibrational H2 emission has been observed by JWST, giving a direct measurement of the CR ionization rate.

    • Shmuel Bialy
    • Amit Chemke
    • Ekaterina I. Makarenko
    Research
    Nature Astronomy
    P: 1-8
  • Inhibition of the histone methyltransferase NSD2 and the androgen receptor in preclinical models can reverse lineage plasticity to suppress tumour growth and promote cell death in multiple subtypes of castration-resistant prostate cancer.

    • Jia J. Li
    • Alessandro Vasciaveo
    • Michael M. Shen
    ResearchOpen Access
    Nature
    Volume: 649, P: 216-226
  • Understanding the mechanisms underlying the survival of drug tolerant persister cells following chemotherapy remains elusive. Here, multi-omics analysis and experimental approaches show that the germ-cell-specific H3K4 methyltransferase PRDM9 promotes metabolic rewiring in glioblastoma stem cells.

    • George L. Joun
    • Emma G. Kempe
    • Lenka Munoz
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-30
  • There are limited vaccines available for Ebola virus and none for broad protection from filoviruses. Here, the authors rationally design vaccines using nanoparticles and stabilized Ebola virus and other filovirus glycoproteins, characterize antibody epitopes and profile lymph node and antibody responses in mice.

    • Yi-Zong Lee
    • Yi-Nan Zhang
    • Jiang Zhu
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-30
  • Here they demonstrate a therapeutic intervention elevating levels of CYP450-derived lipids to control the expansion of intermediate monocytes in tissue and peripheral blood, presenting a first in class therapeutic approach for treating chronic inflammatory disease.

    • Olivia V. Bracken
    • Parinaaz Jalali
    • Derek W. Gilroy
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-17